| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |